LAMA4 and cancer: For this analysis we focused on PDPN (FDR 6.43E-05, fold change 3.62) and LAMA4 (FDR 1.58E-09, fold change 3.77) because these molecules have been previously associated with cancer progression in other tumor types [20–25].